PFM Health Sciences LP Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

PFM Health Sciences LP lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 75,588 shares of the healthcare conglomerate’s stock after selling 46,250 shares during the period. UnitedHealth Group makes up about 2.5% of PFM Health Sciences LP’s portfolio, making the stock its 12th biggest position. PFM Health Sciences LP’s holdings in UnitedHealth Group were worth $44,195,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of UNH. Delta Financial Group Inc. lifted its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after acquiring an additional 17 shares during the period. Signature Resources Capital Management LLC lifted its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC lifted its stake in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares during the period. GoalVest Advisory LLC lifted its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares during the period. Finally, Fiduciary Group LLC lifted its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $610.53 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business’s fifty day simple moving average is $585.43 and its 200-day simple moving average is $556.08. The firm has a market cap of $561.86 billion, a PE ratio of 39.77, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 EPS. The company’s quarterly revenue was up 9.2% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $618.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.